Sumitomo Dainippon Pharma to invest $3 bln in Swiss Roivant
Japan’s Sumitomo Dainippon Pharma
Co will pay $3 billion for a 10% stake in Swiss
drugmaker Roivant Sciences Ltd and interests in five of its
biopharmaceutical businesses, the two companies said on Friday.
Co will pay $3 billion for a 10% stake in Swiss
drugmaker Roivant Sciences Ltd and interests in five of its
biopharmaceutical businesses, the two companies said on Friday.
Posted by Reuters
